There are 2949 resources available
Q&A and live discussion
Presenter: Domenica Lorusso
Session: Proffered Paper - Gynaecological cancers 1
Resources:
Webcast
LBA70_PR - The impact of COVID-19 on oncology professionals: Initial results of the ESMO resilience task force survey collaboration
Presenter: Susana Banerjee
Session: Proffered Paper - SARS-CoV-2 and cancer 1
Resources:
Abstract
Slides
Webcast
396O - Health-related quality of life (HRQoL) in patients (pts) treated with pembrolizumab (pembro) vs chemotherapy as first-line treatment in microsatellite instability-high (MSI-H) and/or deficient mismatch repair (dMMR) metastatic colorectal cancer (mCRC): Phase III KEYNOTE-177 study
Presenter: Thierry André
Session: Proffered Paper - GI, colorectal
Resources:
Abstract
Slides
Webcast
82O - Genomic evolution of metastatic tumours under therapeutic pressure
Presenter: Joris Van De Haar
Session: Proffered Paper - Translational research
Resources:
Abstract
Slides
Webcast
1189O - Validation of whole genome sequencing in routine clinical practice
Presenter: Kim Monkhorst
Session: Proffered Paper - Translational research
Resources:
Abstract
Slides
Webcast
LBA71 - Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection: A CCC19 registry analysis
Presenter: Trisha Wise-draper
Session: Proffered Paper - SARS-CoV-2 and cancer 1
Resources:
Abstract
Slides
Webcast
1670O - Prospective data of first 1,797 hospitalised patients with cancer and COVID-19 derived from the COVID-19 Clinical Information Network and international Severe Acute Respiratory and emerging Infections Consortium, WHO Coronavirus Clinical Characterisation Consortium
Presenter: Carlo Palmieri
Session: Proffered Paper - SARS-CoV-2 and cancer 1
Resources:
Abstract
Slides
Webcast
397O - Avelumab plus cetuximab in pre-treated RAS wild type metastatic colorectal cancer patients as a rechallenge strategy: The phase II CAVE (cetuximab-avelumab) mCRC study
Presenter: Erika Martinelli
Session: Proffered Paper - GI, colorectal
Resources:
Abstract
Slides
Webcast
398O - Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer (CRC) - PRODIGE 13 a FFCD phase III trial
Presenter: Come Lepage
Session: Proffered Paper - GI, colorectal
Resources:
Abstract
Slides
Webcast
399O - Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in elderly patients: A subgroup analysis from TOSCA trial
Presenter: Sara Lonardi
Session: Proffered Paper - GI, colorectal
Resources:
Abstract
Slides
Webcast